Skip to main content

Interwest Venture Management Co

SEC CIK
0001697720
Latest filing
Oct 20, 2023

Holdings in Q4 2021

Holdings as of Dec 31, 2021, filed Jan 25, 2022. Long positions only; changes compare share counts with Q3 2021.

Institution overview
Positions
9
−1 vs. Q3 2021
Portfolio value
$169.2M
−$72.3M (−29.9%) vs. Q3 2021
Filed
Jan 25, 2022
SEC
Holdings of Interwest Venture Management Co in Q4 2021
SecurityClassSharesValue% of portfolioShare changeActionHistory
PMVPPMV Pharmaceuticals, Inc.COM3,234,911$74.7M44.2%−635,000−16.4%ReducedHistory
REALTheRealReal, Inc.COM2,354,080$27.3M16.2%00.0%UnchangedHistory
AIC3.ai, Inc.Stock866,774$27.1M16.0%00.0%UnchangedHistory
SERASera Prognostics, Inc.CLASS A COM2,416,241$16.6M9.8%00.0%UnchangedHistory
GKOSGLAUKOS CorpCOM350,264$15.6M9.2%00.0%UnchangedHistory
EIGREiger BioPharmaceuticals, Inc.COM764,918$3.97M2.3%00.0%UnchangedHistory
AGTCApplied Genetic Technologies CorpCOM1,404,515$2.67M1.6%00.0%UnchangedHistory
VEROVenus Concept Inc.COM658,657$1.12M0.7%00.0%UnchangedHistory
DAREDare Bioscience, Inc.COM62,065$124.0K0.1%00.0%UnchangedHistory

Sold out since Q3 2021 (1)

Positions held at the end of Q3 2021 that are gone from this filing.

Positions of Interwest Venture Management Co sold out since Q3 2021
SecurityClassShares in Q3 2021Value in Q3 2021% of portfolio in Q3 2021History
XENEXenon Pharmaceuticals Inc.COM8,293$127.0K0.1%History